Background: There is epidemiological evidence that perinatal nutritional factors may have long-term effects on obesity. Which nutrients or food components are involved in this programming mechanism are unknown. Breast milk contains leptin, a hormone that regulates food intake and energy expenditure, and previous studies in rats have shown that leptin orally administered during lactation exerts anorexigenic effects. Objective: To evaluate whether supplementation with physiological doses of oral leptin during lactation has long-term effects on body weight regulation. Design: A daily oral dose of leptin (equivalent to five times the amount of leptin ingested normally from maternal milk during the suckling period) or the vehicle was given to suckling male rats during lactation. Animals were fed after weaning with a normal fat (NF) or a high-fat (HF) diet. We followed body weight and food intake of animals until the age of 6 months, and measured the size of adipose tissue depots, the thermogenic capacity, the expression of leptin in the stomach and adipose tissues and the expression of two appetite-related peptides (neuropeptide Y (NPY) and proopiomelanocortin (POMC)), leptin receptor (OB-Rb) and suppressor of cytokine signalling 3 (SOCS-3) in the hypothalamus at the age of 6 months. Results: Leptin-treated animals had, in adulthood, lower body weight and fat content and ate fewer calories than their untreated controls. Unlike adipocitary leptin production, adult animals that were leptin-treated during lactation displayed higher gastric leptin production without changes in OB-Rb mRNA levels. In addition, in response to HF diet, leptin-treated animals (contrary to controls) showed lower hypothalamic NPY/POMC mRNA ratio. Hypothalamic OB-Rb mRNA levels decreased in control animals as an effect of HF diet feeding, but remained unchanged in leptin-treated animals; SOCS-3 mRNA levels were lower in leptin-treated animals than in their controls, both under normal or HF diet. Conclusion: The animals that received leptin during lactation become more protected against fat accumulation in adult life and seem to be more sensitive to the short-and long-term regulation of food intake by leptin. Thus, leptin plays an important role in the earlier stages of neonatal life, as a component of breast milk, in the prevention of later obesity.
Introduction
The cloning of the gene that codifies for leptin 1 opened a new window to understanding the system that controls body weight in mammals. Leptin is a hormone primarily produced and secreted by the adipose tissue, and its circulating levels correlate with the size of fat stores. 2, 3 Leptin signals nutritional status and energy storage levels to feeding centers, through its action on the expression and release of orexigenic and anorexigenic neuropeptides, including, respectively, neuropeptide Y (NPY) and proopiomelanocortin (POMC). 4 In the arcuate nucleus, NPY and POMC neurons express the long form of leptin receptor (OB-Rb), which is functionally coupled to the Janus kinase-signal transducer and activator of transcription intracellular signalling cascade and produces an endogenous inhibitor (suppressor of cytokine signalling 3, SOCS-3) upon activation. 5 This action prompts appropriate regulation of food intake and energy expenditure processes and helps our body to maintain the amount of fat stores within a certain range. 1, 2, 4, 6, 7 However, most obese people appear to be resistant to the action of leptin. In fact, the administration of this hormone, while proven to be effective in reducing fat and normalizing metabolic disorders in leptin-deficient mice and humans, has not proven to be effective in most cases of obesity. 4, [8] [9] [10] Although leptin is mainly produced by the adipose tissue, this hormone is also produced by other tissues, such as stomach, [11] [12] [13] placenta, 14, 15 skeletal muscle 16 and mammary epithelium, 17 and it is naturally present in maternal milk. 18, 19 Although leptin produced by the adipose tissue is known to play a main role in the chronic control of energy balance, the role of leptin produced by the stomach has been related with the short-term control of food intake, acting as a satiety signal. 13, 20 There is evidence indicating that feeding stimulates the secretion of leptin by the stomach in humans 12, 13 and in rats, 11, 21 and pepsinogen secretagogues such as cholecystokinin (CCK), gastrin or secretin also induce gastric leptin release in rats. 11 Leptin receptors are present in the human stomach [22] [23] [24] and in the mouse gastrointestinal tract, 25 and additionally leptin is capable of direct and acute activation of vagal afferent neurons that originate in the gastric and intestinal walls and terminate in the nucleus tractus solitarius, 26 providing rapid information to the brain.
The role of breast milk leptin is not known as yet, but it has been reported that leptin supplied by milk, or leptin supplied as a water solution, can be absorbed by the immature stomach of suckling rats 18, 27, 28 and be transferred to the bloodstream, 18, 28 suggesting that maternal milk leptin may play a regulatory role during development. Leptin supplied from maternal milk appears to be the main source of leptin in the stomach during the suckling period, particularly during the first-half of this period, in which gastric leptin production is kept low. 27 This exogenous leptin could exert biological effects in neonates at a time in which both the adipose tissue and appetite regulatory systems are immature. 26 Of interest, the administration of physiological oral doses of leptin during the suckling period has been shown to inhibit food intake, but without affecting body weight gain during this period, 28 however, whether leptin supply during the lactating period may have longer-term effects, in adulthood, is not known. There is increasing epidemiological evidence suggesting that breastfeeding compared with infant formula confers protection against obesity later in life; 29 however, causality has never been related to any specific compound. Bearing in mind that leptin is naturally present in the human breast milk 18 but not present in infant formula, 30 and our previous findings that, in neonate rats, orally taken leptin can be absorbed by the immature stomach and inhibits food intake, 27, 28 we faced the hypothesis that programming by an early leptin-deficient diet may be a mechanism that links early nutrition with later obesity.
Methods

Animals and experimental design
The study was performed using 30 pups from six different dams, following the same protocol during lactation as described previously. 28 Briefly, 3-month-old virgin female
Wistar rats were mated with male rats (Charles River Laboratories, Barcelona, Spain). After matching, each female was placed in an individual cage with free access to water and food. Rats were kept in a room with controlled temperature (221C) and a 12 h light-dark cycle (light on from 0800 to 2000). At day 1 after delivery, excess pups in each litter were removed in order to keep 10 pups per dam, and they were randomly assigned into two groups: control group and leptin-treated group. From day 1 to day 20 of lactation, and during the first 2 h of the beginning of the light cycle, 20 ml of the vehicle (water) -control group -or a solution of recombinant murine leptin (PeproTech, London, England) dissolved in waterleptin-treated group -was given orally every day to the pups using a pipette. The amount of leptin given to animals was calculated as five times the average amount of the daily leptin intake from the mother's milk. 28 The We considered these doses of leptin to be close to physiological levels of intake, taking into account the range of variation of milk leptin levels in dams. 28 On day 21, after weaning, both control and leptin-treated male rats were singlecaged and were divided into two groups: normal-fat (NF) group À fed on a standard chow diet (3.8 kcal/g) with 10% calories from fat; and high-fat (HF) group À fed on a chow diet (4.7 kcal/g) with 45% calories from fat (Research Diets, Inc., NJ, USA). NF diet contained 5.5% calories from soybean oil and 4.5% from lard; HF diet contained 5.5% calories from soybean oil and 39.5% from lard. Possible differences between litters were solved by ensuring the presence of pups from the same litter in each of the four experimental groups. Body weights and food intake were recorded three times a week from weaning until the age of 6 months.
At the age of 6 months, animals were killed by decapitation under fed conditions, during the first 2 h of the beginning of the light cycle. The hypothalamus, stomach, interscapular brown adipose tissue (BAT) and different white adipose tissue depots (WAT) À gonadal, retroperitoneal, mesenteric and inguinal À were rapidly removed. The stomach was opened and rinsed with saline containing 0.1% diethylpyrocarbonate (Sigma, Madrid, Spain) and the epithelium was scraped off using a glass slide. Brown and WAT were weighed. All samples were immediately frozen in liquid nitrogen and stored at À701C until RNA analysis. Blood was also collected, stored at room temperature for 1 h and overnight at 41C, and was then centrifuged at 1000 g for 10 min to collect the serum, which was stored at À201C until analysis. The animal protocol followed in this study was reviewed and approved by the Bioethical Committee of our University and guidelines for the use and care of laboratory animals of the University were followed.
Quantification of leptin concentration
Leptin concentration was determined in the gastric mucosa and in serum. Gastric mucosa samples were homogenized at Quantification of insulin, ghrelin and glucose concentration Serum insulin concentration was measured using an ELISA kit (DRG Instruments, Marburg, Germany). Serum ghrelin concentration was measured with a rat ghrelin enzyme immunosorbent assay kit (Phoenix Europe GmbH, Karlsruhe, Germany). Glucose concentration was measured enzymatically using a commercial kit, following standard procedures (Roche and R-Biopharm, Darmstadt, Germany).
RNA extraction
Total RNA was extracted from interscapular BAT, different WAT depots (inguinal, retroperitoneal and mesenteric), gastric mucosa and hypothalamus by Tripure Reagent (Roche Diagnostic Gmbh, Mannheim, Germany) according to the manufacturer's instructions. The integrity and concentration of the RNA were confirmed using agarose gel electrophoresis.
Real-time quantitative PCR analysis
Real-time polymerase chain reaction (PCR) was used to measure mRNA expression levels of NPY, POMC, OB-Rb and SOCS-3 in hypothalamus, leptin and OB-Rb in gastric mucosa and leptin in different WAT depots.
Total RNA (0.5 mg) (in a final volume of 25 ml) were denatured at 901C for 1 min and then reverse transcribed to complementary DNA (cDNA) using MuLV reverse transcriptase (Applied Biosystem, Madrid, Spain) at 421C for 1 h, with a final step of 5 min at 991C in a Perkin-Elmer 9700 Thermal Cycler (Perkin-Elmer, Wellesley, MA, USA).
Real-time PCR was completed using the LightCycler System with SYBR Green I sequence nonspecific detection (Roche Diagnostic Gmbh, Mannheim, Germany). Primers for the different genes are described in Table 1 . All primers were obtained from Bonsai Technologies Group, SA (Madrid, Spain).
Each PCR was performed in a total volume of 10 ml, made from diluted (1/50) cDNA template (2 ml), forward and reverse primers (1 mM each), and SYBR Green I master mix (1.8 ml, including Taq polymerase, reaction buffer, MgCl 2 , SYBR Green I dye and dNTP mix). After an initial Taq activation at 951C for 10 min, LightCycler PCR was performed using 40 cycles with the cycling conditions described in Table 1 . In order to verify the purity of the products, a melting curve was produced after each run by increasing the temperature of the reaction mixtures up to 951C, by 0.11C/s, starting at 551C for 10 s. Values for the threshold (Ct) were determined using the LightCycler software.
Relative gene expression numbers were calculated as a percentage of control rats, using the 2 ÀDDCt method 31 with the a-actin as reference gene.
Northern blot analysis mRNA levels for UCP1 in interscapular BAT were determined by Northern blot. Total RNA (30 mg) was denatured with formamide/formaldehyde and then fractionated by agarose Leptin intake during lactation prevents obesity C Picó et al gel electrophoresis as described previously. 32 The RNA was transferred onto a Nylon membrane (Roche, Barcelona, Spain) in 20 Â saline sodium citrate buffer (SSC; 1 Â SSC is 150 mM NaCl, 15 mM sodium citrate, pH 7.0) by capillary blotting for 16 h and fixed with UV light. UCP1 mRNA was detected by a chemiluminescence-based procedure, using the antisense oligonucleotide probe 5 0 -GTTGGTTTTATTCGTGGTCTCCCAGCATAG-3 0 synthesized commercially (Genoteck, Ebergberg, Germany), and labelled at both ends with a single digoxigenin ligand. Prehybridization was at 421C for 15 min in DIG-Easy Hyb (Roche, Barcelona, Spain). Hybridization was at 421C overnight in DIG-Easy Hyb containing 35 ng/ml of the oligonucleotide probe. Then, hybridized membranes were washed twice for 15 min at room temperature with 2 Â SSC/0.1% sodium dodecyl sulphate (SDS), followed by two 15 min washes at 481C with 0.1 Â SSC/0.1% SDS. After 1 h blocking at room temperature with Blocking reagent (Roche, Barcelona, Spain), the membranes were incubated first with antidigoxigenin-alkaline phosphatase conjugate (Roche, Barcelona, Spain) and then with the chemiluminescent substrate CDPStar (Roche, Barcelona, Spain). Finally, membranes were exposed to Hyperfilm enhanced chemiluminescence detection system (ECL) (Amersham Biosciences, Barcelona, Spain). The films were scanned in a Chemigenius BioImaging System (Syngene, UK), and the bands were quantified using the GeneTools Software (Syngene, UK). Finally, blots were stripped by 10 min exposure to boiling 0.1% SDS and reprobed for 18S rRNA detection, to check the loading and transfer of RNA during the blotting. For 18S rRNA, the 31-mer digoxigenin-labelled antisense oligonucleotide 5 0 CGCCTGCTGCCTTCCTTGGATGTGGTAGCCG-3 0 at a concentration of 70 pg/ml was used.
Western blot analysis UCP1 analysis in interscapular BAT was performed by Western blot. BAT was homogenized at 41C in 1:5 (w:v) of PBS in a Teflon glass homogenizer. The homogenate was centrifuged at 7000 g for 2 min at 41C and the supernatant used for total protein and UCP1 analysis. Total protein content was measured by the method of Bradford. 33 For UCP1 analysis, 25 mg of total protein were fractionated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE; 10% polyacrylamide) according to Laemmli, 34 and electrotransferred onto a nitrocellulose membrane (Bio-Rad, Madrid, Spain). After blocking, the membrane was incubated with the primary rabbit polyclonal anti-UCP1 antibody (Alpha Diagnostic, San Antonio, TX, USA), diluted 1:1000, and then with the secondary biotinylated anti-rabbit IgG antibody conjugated to a streptavidin-biotinylated horseradish peroxidase complex (Amersham Biosciences, Barcelona, Spain) diluted 1:5000. The immunocomplexes were revealed using an ECL (Amersham Biosciences, Barcelona, Spain). Membranes were exposed to Hyperfilm ECL (Amersham Biosciences, Barcelona, Spain). The films were scanned and quantified as described above.
Statistical analysis
Data are expressed as means7s.e.m. (n ¼ 6-8). Two-way analysis of variance (ANOVA) with the factors of leptin treatment and diet was performed to assess statistical significances. When the ANOVA indicated a significant interaction between effects, individual means were compared with least significant difference (LSD) post hoc test.
Results
We show here ( Figure 1) . In adult animals, the lower body weight in leptin-treated rats can be explained by lower fat content (Table 2) . At the age of 6 months, the weights of the inguinal and the mesenteric fat depots were significantly reduced as an effect of leptin treatment (Po0.05, two-way ANOVA). The gonadal and the retroperitoneal fat depots were also slightly reduced in both NF and HF diet fed leptin-treated animals, compared with their controls. BAT weight was not affected by leptin treatment. Glucose, insulin and ghrelin concentrations in serum were not significantly affected by the leptin treatment, either in NF or in HF diet fed animals ( Table 2 ). Neither did we find significant changes in glucose and ghrelin concentrations as effect of HF diet feeding. Serum insulin concentration was higher in control and leptin-treated animals under HF diet, compared with NF diet fed animals (Po0.05, two-way ANOVA).
In accordance with lower adipose mass, circulating leptin concentration was slightly reduced in leptin-treated rats, both under NF and HF diets ( Table 2) . Leptin mRNA expression levels were also lower in the mesenteric fat depot in leptin-treated rats under both NF and HF diets (Po0.05, two-way ANOVA), as well as in the inguinal and the retroperitoneal fat depots, but only under NF diet (Table 3) . Of note, the higher effect observed in the mesenteric adipose tissue agrees with previous reports 35, 36 showing that this depot seems to be especially sensitive to changes in food intake.
The effect of leptin treatment on body weight can be partially explained by lower food intake ( Table 2) .
Leptin intake during lactation prevents obesity C Picó et al Cumulative food intake until the age of 3 months (from day 21 to 3 months of life) was slightly lower, but not significantly different, in leptin-treated animals both under NF and HF diets (4.5 and 4.2% decrease, respectively), but differences were more marked from 3 to 6 months of life (7.2 and 6.2% decrease, respectively). Considering the whole studied period from day 21 to 6 months of age, food intake was significantly lower in leptin-treated animals vs their controls (Po0.05, twoway ANOVA). Both control and leptin-treated animals ate more calories under HF than under NF (Po0.05, two-way ANOVA). The mRNA and protein levels of BAT UCP1, the key biological marker of adaptive thermogenesis in rodents, were not affected by leptin treatment (Table 3) . Of note, leptin expression by the stomach was higher in leptin-treated animals than in their untreated controls, both under NF and HF diets (49 and 55% increase, respectively) (Po0.05, two-way ANOVA), with no changes in gastric leptin levels, suggesting gastric leptin is produced and secreted at higher amounts in leptin-treated animals (Figures 2a and b) . Leptin receptor mRNA levels remained unchanged in the different groups of animals ( Figure 2c ). Gastric ghrelin production was also unchanged in the different groups of animals (data not shown). Table 3 Leptin mRNA levels in different representative WAT depots (inguinal, iWAT, mesenteric, mWAT, and retroperitoneal, rpWAT), and UCP1 mRNA levels and UCP1 protein levels in the interscapular BAT of 6-month-old rats that received a daily oral dose of leptin or the vehicle during lactation, and were fed after weaning with an NF or an HF diet Leptin intake during lactation prevents obesity C Picó et al
We also studied hypothalamic expression of neuropeptides regulated by leptin and involved in food intake control, as well as the expression of OB-Rb and SOCS-3, in order to assess leptin resistance as an effect of HF diet feeding (Figure 3) . NPY mRNA levels were significantly higher under HF diet in both control and leptin-treated animals (Po0.05, two-way ANOVA), but were not altered as an effect of the leptin treatment (Figure 3a) . Concerning hypothalamic POMC expression, the effect of HF diet feeding was different in control and leptin-treated rats: whereas mRNA levels remained unchanged in control animals, they increased in leptin-treated animals (Figure 3b ). However, under NF diet, leptin-treated animals displayed lower POMC mRNA expression levels than controls. Considering that both NPY and POMC are the main neuropeptides stimulating and inhibiting food intake respectively, it is interesting to highlight that, in control animals, the NPY/POMC mRNA ratio increased significantly as an effect of HF diet feeding (values were 1.1470.33 in the NF group and 2.2370.41 in the HF group, 96% increase) (Po0.05, LSD post hoc test), whereas in leptin-treated animals, this ratio decreased significantly (values were 2.1370.19 in the NF group and 1.2270.12 in the HF group, 43% decrease) (Po0.05, LSD post hoc test); this could help to better control food intake and thus body weight in leptin-treated animals under HF diet. The expression levels of the orexigenic neuropeptide regulated by leptin cocaine-amphetamine-related transcript (CART), the inhibitor of melanocortin receptor function agouti-related protein (AGRP) and the melanocortin 4 receptor (MC4-R) were not affected either by leptin treatment or by HF feeding (data not shown). mRNA levels encoding the long leptin receptor isoform (OB-Rb) in the hypothalamus were similar in control and leptin-treated animals under NF diet (Figure 3c ). However, under HF diet, OB-Rb mRNA levels decreased significantly in control animals, probably indicating leptin resistance at hypothalamic level, but remained unchanged in leptin-treated animals (Po0.05, LSD post hoc test). SOCS-3 mRNA levels were significantly lower in leptintreated animals than in their untreated controls both under NF or HF diet (Po0.05, two-way ANOVA) (Figure 3d) . No changes were observed in SOCS-3 mRNA levels in either control or leptin-treated animals as effect of HF diet feeding.
Discussion
Obesity is now called a global epidemic because its prevalence and severity are increasing worldwide at alarming rates, both in adults and in children. 37 As obesity treatment entails huge costs, the development of effective strategies for primary prevention is particularly attractive. Despite epidemiological evidence from a variety of sources that perinatal nutritional factors have long-term effects on obesity predisposition, 38, 39 nothing is known about which specific food components are responsible for that. The novel and main finding of this study is that the intake of moderate amounts of leptin by suckling rats prevents the development of overweight/obesity in later life. We previously reported that physiological doses of leptin orally administered to neonate rats are able to be absorbed by receptor (OB-Rb) mRNA levels (c) in the gastric mucosa of 6-month-old rats that received a daily oral dose of leptin or the vehicle during lactation, and were fed after weaning with an NF or an HF diet. Leptin and leptin receptor mRNA levels were measured by real-time PCR and expressed as a percentage of the value of control animals under NF diet. Leptin concentration was measured using an ELISA kit and expressed as pg/g of gastric mucosa. Results are mean7s.e.m. of six to eight animals per group. L, effect of leptin treatment (Po0.05, two-way ANOVA).
Leptin intake during lactation prevents obesity C Picó et al the immature stomach and exert anorexigenic effects, but without affecting body weight and body fat content of animals during the lactation period. 28 Thus, from these previous studies it was proposed that oral intake of leptin during lactation could play a role in the short-term control of food intake in neonates, probably acting on its receptors in the stomach and the vagal afferent neurons that enervate the gastric and intestinal wall. Moreover, since in suckling rats leptin present in the gastric lumen also passes to the bloodstream, 18, 28 it was suggested that leptin from an oral source could have additional systemic effects, perhaps by acting on its hypothalamic receptors, and also have further long-term effects. Thus, the aim of this study was to explore whether chronic intake of moderate doses of leptin during lactation might have further effects on development and affect body weight control of adult rats. Increased chronic intake of leptin during lactation had no significant effects on body weight at weaning. In a previous study following the same protocol, 28 we also described no effects on body fat content. These results appear to be different from those of Schmidt et al. 40 showing that daily subcutaneous administration of pharmacological doses of leptin (2 Â 50 (pmol/g)day) during the suckling period resulted in lower body fat from day 7 of life onwards. Differences between both studies can be attributed to the different ways of leptin administration and also to the different doses of leptin used, much higher in the study of Schmidt et al. Of interest, we found here that increased chronic intake of leptin during lactation has long-term effects on body weight control: rats seem to be more resistant to age-related body weight increase and to diet-induced overweight in adulthood. This effect was significant from day 84 onwards in animals under NF or HF diet. Of note, leptin-treatment during lactation was enough to prevent the excess of body weight gain owing to HF diet feeding, and these animals had a similar body weight to untreated control animals under NF diet. At the age of 6 months, leptin-treated animals also displayed circulating leptin levels slightly lower than their respective controls, both under NF or HF diet, in accordance with their lower fat Leptin intake during lactation prevents obesity C Picó et al mass, although these differences did not reach statistical significance. Differences in body weight between control and leptintreated animals can be partially explained by differences in food intake: leptin-treated animals ate fewer calories than untreated controls, particularly from month 3 onwards. Concerning energy expenditure, based on the absence of an effect on BAT weight and on mRNA and protein levels of UCP1, the key biological marker of adaptive thermogenesis in rodents, 41 differences in thermogenesis do not seem a major factor in the effects observed by leptin treatment on body weight. It is well known that the adipose tissue in adult animals is the main contributor to blood leptin levels, and that systemic leptin plays a main role in the central control of food intake. 7 On the other hand, leptin produced by the gastric mucosa and released in response to food intake may play a role in the short-term regulation of food intake by acting as a satiety signal. [11] [12] [13] 20 It is known that food intake stimulates leptin expression by the gastric mucosa, 21 but other unknown factors are probably involved in modulating this effect. Of interest, leptin mRNA expression levels in the gastric mucosa were significantly higher in leptin-treated animals than in their untreated controls, both under NF and HF diets, whereas steady-state levels of the protein were similar in all groups of animals. This suggests that gastric leptin is produced and secreted at higher amounts in leptintreated animals. Leptin receptor mRNA levels in the stomach remained unchanged in the different groups of animals. All in all, these results suggest that short-term control of food intake mediated by gastric leptin is more active in leptintreated animals and this could be partially responsible for their lower food intake. Increased leptin production by the stomach in leptin-treated rats was not seen in a previous study when rats were 21-day-old, 28 probably because of the inhibitory effect exerted by oral leptin on gastric leptin expression. 27, 28 At the hypothalamic level, differences in neuropeptide expression can contribute to explain the lower food intake in leptin-treated rats, compared with their controls. Leptin and insulin are thought to regulate feeding behaviour through their abilities to regulate transcription of several neuropeptide genes, including NPY. Animals fed an HF diet have significantly higher insulin levels and slightly higher leptin levels. NPY is an important regulator of food intake and energy metabolism, with orexigenic activity. 42 Enhanced levels of NPY and of NPY mRNA expression have been described in the hypothalamus of obese rodents. 43 We found higher NPY expression in the hypothalamus of control and leptin-treated animals under HF diet, which is suggestive of both leptin and insulin resistance, and could be partially responsible for the overfeeding of rats under this diet. Increased NPY expression has also been described when feeding rats for 14 days with an HF diet. 44 We did not find significant differences between control and leptin-treated animals concerning NPY expression. However, it is noticeable that leptin-treated animals, but not control animals, had a compensatory increase in POMC expression under HF diet. POMC is the precursor of a-MSH, which is a potent inhibitor of food intake and is considered to be the predominant pathway regulating food intake in adults. 45 The observed overexpression of POMC in leptin-treated animals under HF diet could be explained by higher leptin action on their receptor and could counteract the effect of HF diet on positive energy balance, in an effort to maintain energy homeostasis. These results are in line with the findings of Bergen et al. 46 showing compensatory hypothalamic changes in mRNA expression levels of POMC in A/J mice (resistant to diet-induced obesity) fed with HF diet for 14 weeks. Considering that both NPY and POMC are the main neuropeptides stimulating and inhibiting food intake, respectively, it is interesting to highlight that, in control animals, the NPY/POMC ratio increased as an effect of HF diet feeding, whereas in leptin-treated animals, this ratio decreased significantly; this could help to control food intake and thus body weight in leptin-treated animals under HF diet. However, by measuring mRNA expression in the whole hypothalamus we cannot precisely ensure that the observed changes took place within the arcuate paraventricular axis. On the other hand, POMC mRNA expression levels in leptin-treated animals under NF diet were lower than in their untreated controls; this could be explained by lower circulating leptin levels, although differences were not statistically significant. The decreased expression of POMC in these animals cannot explain the hypophagia and the lower body weight of these animals compared with their untreated controls. This suggests that leptin treatment may affect other processes that could counteract the decreased expression of POMC in these animals, for example, the observed higher leptin production by the stomach. The responsiveness of the hypothalamus to the inhibitory effects of leptin on food intake and body weight depends not only on the levels of circulating leptin but also on factors determining leptin sensitivity, such as leptin receptors (OB-R), the responsiveness of intracellular signal transduction or the cytokine inhibitory protein SOCS-3. 47, 48 The two dominant OB-R forms in humans and rodents are OB-Ra and OB-Rb, which differ within the intracellular domains. The longer form, the OB-Rb, is primarily expressed in distinct nuclei of the hypothalamus and is considered to be the signalling-competent isoform. 47 This form is sensitive to genetic and physiological interventions that change circulating leptin levels, indicating that overexpression of OB-Rb in the hypothalamus may contribute to increased leptin sensitivity. 47 Here, we measured the expression of OB-Rb in the hypothalamus to evaluate possible differences in leptin responsiveness between control and leptin-treated rats under NF or HF diet feeding. We found decreased OB-Rb mRNA levels in the hypothalamus of control rats under HF diet, whereas levels were unaffected in leptin-treated rats under HF diet, probably reflecting their higher resistance to obesity development. Thus, leptin treatment seems to protect
Leptin intake during lactation prevents obesity C Picó et al animals against leptin-resistance induced by HF diet feeding. This is in agreement with results from other authors showing a marked suppression of leptin signalling in the hypothalamus of mice fed with an HF diet for 19 weeks 49 and a decrease in the expression of OB-Rb in the hypothalamus of rats fed with cafeteria diet for 10 weeks. 50 Other authors did not find significant changes in OB-Rb mRNA levels in the hypothalamus of Wistar rats fed with HF diet, 48 or in two rat strains with different susceptibility to becoming obese when exposed to dietary manipulations, the Osborne-Mendel (OM) rats (susceptible) and the S5B/P1 rats (highly resistant). 51 However, in these latter rat strains (OM and S5B/P1), receptor protein levels (both the short and the long form) were downregulated after 14 days HF diet feeding. 51 SOCS-3 is a leptin-inducible inhibitor of leptin signalling, and a potential mediator of leptin resistance in obesity. 52 Of interest, we found significantly lower SOCS-3 mRNA levels in leptin-treated animals than in their untreated controls both under NF (45% reduction) or HF diet (31% reduction). This reduction might be enough to both increase leptin action and to attenuate sensitivity to diet-induced obesity. This is supported by the fact that mice that are heterozygous for an SOCS-3 gene deletion, and hence have a 50% reduction of SOCS-3 expression, exhibit enhanced OB-Rb activation induced by leptin. 53 Moreover, these animals have increased sensitivity to the weight-reducing effect of leptin and are resistant to development of diet-induced obesity. 53 SOCS-3 is also an inhibitor of insulin signalling, 54 and insulin has been reported to require signalling proteins and pathways in the CNS that overlap with those of leptin to influence energy balance. 55 Thus, it cannot be ruled out that leptin-treatment of rats during suckling period could also help insulin signalling in adulthood. The early programming mechanisms induced by leptin are not yet known, but appear to affect the leptin signalling system in adulthood, resulting in adaptive changes in the control of food intake which help to better regulate energy balance. Leptin is known to be actively involved in the development of key organs, such as the brain. 56 In fact, it has been reported that neural projection pathways from the arcuate nucleus of the hypothalamus are permanently disrupted in leptin-deficient (Lep ob /Lep ob ) mice, and leptin treatment in adulthood does not reverse these neuroanatomical defects. However, treatment of Lep ob /Lep ob neonates with exogenous leptin rescues the development of these neural projections pathways. 57 Thus, leptin seems to be required during a neonatal critical period for normal postnatal development of hypothalamic pathways in the arcuate nucleus, which are important because they convey leptin signals to brain regions regulating body weight, 56, 57 thus altering the impact of leptin on energy homeostasis throughout life. Whether changes in the amount of leptin intake during lactation affect the normal development of hypothalamic pathways or other programming mechanisms of metabolic imprinting deserves further investigation.
Leptin concentration in human milk varies widely between people. 18, 19 Some authors have found a positive correlation between maternal BMI or adiposity and milk leptin concentration. 19, 58 We studied milk leptin concentration during the lactating period in a group of 28 non-obese mothers and also found a wide variation, ranging from values under the detection limit of the assay (o0.0078 ng/ml) to 0.853 ng/ml, with a mean value of 0.156 ng/ml. 59 Considering the amount of leptin supplied to rats in the present study (five times the average amount of the daily leptin intake from the mother's milk), if this could be extrapolated to humans, the amount of leptin to be supplied would be within the range of physiological doses of leptin intake from maternal milk. In summary, the results presented here show that the intake of physiological amounts of leptin during lactation may therefore ameliorate or prevent diet-induced overweight/obesity in adulthood. Bearing in mind that leptin is naturally present in human breast milk 18 but is not present in infant formula, 30 this may have important implications for the prevention of obesity and its medical and socioeconomic complications, and may open new ways to understanding the extensive role of leptin in biological processes.
